Introduction
============

Alcohol abuse is characterized in part by short-term and long-term biochemical alterations in brain regions that affect subsequent intake, withdrawal, relapse, and cognition. The majority of research conducted in this area has focused on alterations in midbrain and forebrain regions within the mesolimbic dopamine system that mediate hypothetical motivational processes (Di Chiara and Imperato, [@B16]; Brodie et al., [@B10]). More recently, the prefrontal cortex has received increasing attention in addiction processes because alcoholics show deficits in decision-making like those of individuals with damage to specific prefrontal fields. In particular, damage to either the dorsolateral prefrontal cortex (DLPFC) or orbitofrontal cortex (OFC), produce impairments that suggest that these fields may be contributing substrates in alcoholism (Bechara, [@B6]; Pears et al., [@B56]). Results from functional imaging studies support the idea of alcohol-induced prefrontal cortical alterations. Functional magnetic resonance imaging (fMRI) has revealed increased activation of the medial frontal, orbitofrontal, and cingulate cortices that is correlated with self-reported alcohol-induced craving (Wrase et al., [@B82]; Myrick et al., [@B50]). Furthermore, a priming dose of alcohol sensitizes cue-induced responses in these regions (Bragulat et al., [@B9]). Such findings support the hypothesis that prefrontal cortical dysregulation is involved in the mediation of craving and compulsive alcohol intake (Volkow and Fowler, [@B80]).

Despite evidence linking excessive alcohol intake to dysfunction of specific prefrontal cortical regions, studies exploring biochemical correlates in prefrontal cortex have been limited to human post-mortem tissue analysis (Mitsuyama et al., [@B46]; Mayfield et al., [@B45]; Alexander-Kaufman et al., [@B2]). The use of a non-human primate model of ethanol self-administration enables a clinically relevant characterization of chronic alcohol intake in a well-controlled laboratory setting without confounding variables inherent in human post-mortem studies (e.g., reliable intake measures, lifestyle characteristics, multidrug histories, etc.). The model exhibits important aspects of human alcohol consumption, including an alcoholic drinking phenotype confirmed with blood ethanol concentrations (BEC; Grant et al., [@B25]). Moreover, non-human primate cortex exhibits significant anatomical and biochemical similarities with human cortex that facilitate the translation of findings to humans (Preuss, [@B60]). Previous studies using this model have found marked alterations in GABA-A and NMDA receptor subunit mRNA expression in the DLPFC and OFC but not in anterior cingulate cortex (ACC; Hemby et al., [@B26]; Acosta et al., [@B1]), suggesting region specific GABA/glutamate imbalances in the primate prefrontal cortex.

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate receptors comprise two additional families of glutamate-gated ion channel receptors (Ozawa et al., [@B53]). AMPA and kainate receptors are critical for fast synaptic transmission and have important roles in neuronal development and long- and short-term neuroplasticity (Pinheiro and Mulle, [@B58]). AMPA and kainate receptors are tetrameric assemblies of subunits composed of GluR1--4 and GluR5--7, KA1 and KA2 subunits, respectively (Keinanen et al., [@B35]; Rosenmund et al., [@B65]). AMPA receptors are responsible for the majority of fast excitatory synaptic transmission in the brain and their activation is necessary for depolarization and release the tonic Mg^2+^ blockade of NMDA receptors, thereby enabling NMDA receptor activation. AMPA receptor subunits undergo post-transcriptional processing including alternative splicing to yield *flip* and *flop* variants that mediate receptor desensitization (Quirk et al., [@B61]), the rate of receptor re-sensitization (Partin et al., [@B55]) and of channel closing (Pei et al., [@B57]), thereby enabling greater diversity in channel kinetics and pharmacological profiles for these receptors. Kainate receptors are closely related to AMPA receptors but constitute a separate family of ionotropic glutamate receptor (iGluR) and have unique roles on synaptic transmission depending on receptor subunit composition and whether they are located pre- or post-synaptically (Huettner, [@B29]; Plested and Mayer, [@B59]).

The intoxicating and reinforcing effects of ethanol are mediated in part by the effects on AMPA and kainate receptors (Valenzuela and Cardoso, [@B76]; Backstrom and Hyytia, [@B4]; Sanchis-Segura et al., [@B66]; Jones et al., [@B34]; Palachick et al., [@B54]; Stuber et al., [@B70]). Previous studies have demonstrated that acute ethanol decreases AMPA and kainate receptor-mediated currents in a variety of limbic brain regions (Weiner et al., [@B81]; Crowder et al., [@B15]; Carta et al., [@B13]; Moykkynen et al., [@B49]; Stuber et al., [@B70]). Chronic intermittent ethanol administration, by contrast, has been shown to increase AMPA and kainate receptor-mediated transmission in the basolateral amygdala (Lack et al., [@B40], [@B39]) and increase GluR3 flip variant mRNA expression in the hippocampus of rats (Bruckner et al., [@B11]).

These studies and others have shed considerable light on the involvement of AMPA/kainate receptors in alcohol abuse as well as the effects of alcohol on the expression and function of these receptor classes; however, few studies have attempted to examine the effects of chronic ethanol administration in primate prefrontal cortical regions. Studies using human alcoholic post-mortem tissue provide typically contain several confounding variables (e.g., comorbid psychiatric conditions, periodicity and chronicity of consumption, polysubstance use and abuse) that have a direct impact on multiple biochemical measures. Non-human primate models more closely approximate the neuroanatomical and biochemical milieu of the human brain. The primate cerebral cortex is highly elaborated in comparison to rodents especially in prefrontal regions that are emerging as important substrates for addictive disorders. In the rat, the prefrontal cortex is composed only of a set of agranular fields (e.g., dorsal and ventral anterior cingulate, prelimbic and infralimbic fields) and lacks the intricate expansion found in primates. The primate brain contains agranular fields as well but adds dysgranular and granular fields that are not found in rodents (Carmichael and Price, [@B12]; Ongur and Price, [@B52]). The use of non-human primate models enables a clear and clinically relevant characterization of behavioral and biochemical changes associated with chronic alcohol use in a well-controlled laboratory setting. To further investigate the potential contribution of AMPA and kainate receptor subunit expression in the prefrontal cortical dysfunction characteristic of alcoholism, we examined AMPA and kainate receptor subunit mRNA expression, including AMPA flip/flop variants in the DLPFC, OFC, and ACC of cynomolgus monkeys following chronic ethanol self-administration.

Experimental Procedures
=======================

Subjects and ethanol self-administration
----------------------------------------

Ten adult male cynomolgus monkeys (*Macaca fascicularis*; 5.5--6.5 years at beginning of experiment) were subjects for the present experiments (*n* = 6 ethanol group, *n* = 4 control group). The drinking model and the animals behavior has been extensively analyzed elsewhere (Vivian et al., [@B79]; Grant et al., [@B25]). Six adult male cynomolgus monkeys were quarantined for 2 months and then transferred to the laboratory primate housing room and assigned a cage within a quadrant rack as described previously. Attached to one wall of each monkey's home cage was an operant panel that allowed access to all fluid and food requirements. Monkeys were trained to operate the drinking panel in daily 60-min sessions and then induced to drink water and later ethanol (4% w/v in water). Following 120 days of induction, scheduled pellet delivery was discontinued. For 6 months, ethanol and water were available *ad libitum* and food was available in meals during daily 16-h sessions. Following that, the monkeys underwent ethanol abstinence for 12 months. After the abstinence period, the monkeys were again allowed access to 4% ethanol, water, or food from the panel for 22 h/d for a range of 558--595 consecutive days (approximately 18 months). During the *ad libitum* period monkeys were allowed to self-administer 4% (w/v) ethanol daily, with the volume and rate of alcohol consumed determined solely by the monkey. Once the animals are given free access to ethanol, the onset of daily 22-h sessions are signaled by the illumination of amber stimulus lights above both drinking spouts. Both 4% (w/v) alcohol and water were available at all times during the daily 22-h sessions. In addition, a "meal structure" was imposed so monkeys were required to eat the daily allotment of food in no less than three "meals," with at least 2 h between each meal.

Experimentally naïve control subjects (*n* = 4) were the same as those described previously (Hemby et al., [@B26]; Acosta et al., [@B1]). Following 2 months of quarantine, monkeys were placed on the same diet as the ethanol-drinking animals (Vivian et al., [@B79]) and had very similar daily routines as the ethanol-drinking animals. Control individuals remained in the laboratory for 6 months prior to euthanasia.

Blood samples (20 μl) for the analysis of BEC were taken from the saphenous vein every fifth day from every monkey just before the lights turning off in the room and approximately 7 h following the onset of the session. Blood samples were sealed in air-tight vials containing 500 μl of distilled water and 20 μl of isopropanol (10%; internal standard) and stored at -4°C until assay using a gas chromatograph (Hewlett--Packard 5890 Series II, Avondale, PA, USA) equipped with a headspace autosampler, flame ionization detector, and a Hewlett--Packard 3392A integrator. All behavioral studies were conducted in the laboratory of Dr. Grant at Wake Forest University. The care of the animals and euthanasia procedures in this study were performed according to the National Institutes for Health Guide for the Care and Use of Laboratory Animals, and were approved by the Institutional Animal Care and Use Committee of Wake Forest University.

Necropsy
--------

Following euthanasia and removal of the brain, the prefrontal cortex was dissected from the rest of the brain and the OFC (Area 13), ACC (Area 24), and DLPFC (Area 46) were dissected as described previously (Hemby et al., [@B26]). The OFC dissection included the medial and lateral aspects of the medial orbital sulcus located rostral to the rostral end of the corpus callosum, and therefore included Areas 13a and 13m (Carmichael and Price, [@B12]). The ACC was dissected from the rostral pole of the corpus callosum and included tissue from the cingulate gyrus up to but not including the lower bank of the cingulate sulcus, and therefore contained fields 24a and 24b. The DLPFC (Area 46) was dissected from the banks of the principle sulcus midway along its length.

RNA isolation and cDNA synthesis
--------------------------------

Total RNA was isolated using Trizol (Sigma-Aldrich, St. Louis, MO, USA) followed by chloroform extraction/isopropanol precipitation and stored at −80°C. Two microgram of total RNA from each sample, as well as a pool of total RNA combined from the 10 cynomolgus monkeys, was reverse transcribed using random primers and SuperScript III kits (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Resulting cDNA product was diluted 1:100 with RNAse-free water for samples, and cDNA from the pooled samples was serially diluted in twofold dilutions from 1:20 to 1:640 for use as standards.

Real-time quantitative PCR
--------------------------

Custom Taqman assays were designed for the eight AMPA subunit splice variants in collaboration with Applied Biosystems (Foster City, CA, USA). All assays used FAM reporter dye and NFQ quencher and were designed such that the Taqman probe spanned the exon--exon junction (or included exon) that is specific to the splice variant being measured. Sequence information for these assays is listed in Table [1](#T1){ref-type="table"}. Standard Taqman assays were purchased for measurement of specific kainate receptor subunits and synaptic proteins (GRIA1: Hs00181348_m1; GRIA2: Hs00181331_m1; GRIA3: Hs00241485_m1; GRIA4: Hs00168163_m1; GRIK1: Hs00168165_m1; GRIK2: Hs00222637_m1; GRIK3: Hs00168182_m1, GRIK4: Hs00205979_m1; GRIK5: Hs00361590_m1; PICK1: Hs00202661_m1; GRIP: Hs00294733_m1; Applied Biosystems, Foster City, CA, USA).

###### 

**Sequence information for custom designed AMPA splice variant TaqMan assays**.

  Gene         Probe sequence        Forward primer             Reverse primer            Size
  ------------ --------------------- -------------------------- ------------------------- ------
  GluR1 flip   CACTGAGTTTCAAAACCG    CTCCTGGAGTCCACCATGAATG     CGGAGTCCTTGCTTCCACATT     229
  GluR1 flop   CCCCTGCTCGTTTAGTTT    TGGAGTCCACCATGAATGAGTACA   ACCTCCCCCGCTGC            224
  GluR2 flip   ACCCCAGTAAATCTTG      TGGATTCCAAAGGCTATGGCATC    CCTTGGCTCCACATTCACCTT     150
  GluR2 flop   CCTCGCAGTACTAAAAC     AACCTGGATTCCAAAGGCTATGG    CCGCTGCCGCACTCT           152
  GluR3 flip   CAGTGAACAAGGCATCTTA   AGGCTATGGTGTGGCAACC        GGAGTCCTTGGCTCCACATTC     145
  GluR3 flop   AACTGAATGAGCAAGGCCT   TGGATTCCAAAGGCTATGGTGTG    CCGCTGCCGCACTC            148
  GluR4 flip   CAGTGAGGCAGGCGTC      AGCAGCGAAAGCCATGTGA        AGAGTCTTTGGGTCCACATTCAC   197
  GluR4 flop   AAGGCCTCTTGGACAAAT    GAGCAGCGAAAGCCATGTG        AGTCACCTCCCCCGCT          202

Using a 384 well format with the ABI Prism 7900HTS real-time detector, 0.5 μl aliquots of Taqman Expression Assay (20×), 5.0 μl 2× Absolute QPCR ROX PCR Mastermix (Abgene), and 4.5 μl diluted cDNA (either sample or pooled standard) were mixed together and pipetted into single wells of the PCR plate. For no template controls (NTC) for each gene tested, water was added in lieu of cDNA. Each sample, including NTC was run in triplicate. Thermocycling conditions: (1) one cycle 2 min at 50°C, (2) one cycle 15 min at 95°C, and (3) 40 cycles 15 s at 95°C and 1 min at 60°C. Fluorescence was measured during the 60°C step for each cycle. Reactions were quantified by the standard curve method using SDS2.1 software generating a mean quantity value (Qty mean) for each sample from the triplicates of that sample for each gene of interest. Endogenous controls were selected from a set of seven candidate reference transcripts: β-actin (ACTB: Hs99999903_m1), ribosomal protein 18S (18S: Hs99999901_m1), TATA box binding protein (TBP: Hs99999910_m1), hypoxanthine phosphoribosyltransferase 1 (HPRT1), peptidylprolylisomerase A (cyclophilin A) (PPIA: Hs99999904_m1), β-glucuronidase (GUSB), and phosphoglycerate kinase 1 (PGK1: Hs99999906_m1) using geNorm software. geNorm is a collection of VBA macros for Microsoft Excel which allows the determination of the most stable reference genes from a given test panel of genes. By computing the average pairwise variation (V) for each control gene paired with all other tested control genes, geNorm calculates the gene expression stability measure (M). This allows for the selection of the most stably expressed control genes in a given sample set, minimizing any bias in the data as a result of normalization. The gene expression normalization factor is calculated based on the geometric mean of a user-defined number of reference genes (Vandesompele et al., [@B77]). Three candidate genes, PGK1, TBP, HPRT, were selected to serve as endogenous controls. Data for each gene of interest was expressed as Qty mean for the gene of interest/geometric mean of Qty mean values for the selected endogenous control genes. Normalized values are expressed as percent control.

Statistical analysis
--------------------

Levels of gene expression were calculated using SDS 2.1 software (Applied Biosystems, Foster City, CA, USA) to interpolate the *C*~t~ values for each well onto a standard curve generated from the *C*~t~ values of a dilution series of standards. These quantity values were then averaged across triplicates after removal of outliers and expressed relative to the quantity value for the mean of the endogenous control genes measured in the same sample on the same plate. This relative value (gene of interest Qty mean/endogenous control Qty mean) was used for subsequent statistical analysis. Experiments determining relative gene expression for each candidate gene were run independently. For each gene, two-way analysis of variance was employed with Group (Ethanol and Control) and Subunit (per receptor class) as the Main factors and mRNA abundance as the dependent variable. All subunits for a receptor class were analyzed for each brain regions separately. Bonferroni's test was used for *post hoc* analyses. In addition, Pearson Correlation analysis was conducted for each transcript with average daily ethanol intake for the final 6 months prior to necropsy, total intake over the 18-month period and the BEC for the final 6 months prior to necropsy. Null hypotheses were rejected when *P* \< 0.05.

Results
=======

Individual drinking patterns of the six monkeys included in this study have been reported previously (Vivian et al., [@B79]; Hemby et al., [@B26]). The average daily ethanol intake for 6 months of self-administration prior to necropsy ranged from 1.4 to 3.7 g/kg ethanol and the average BEC ranged from 62 to 188 g/kg. Mean daily ethanol intake, total intake, and BEC are provided in Table [2](#T2){ref-type="table"}. Estimations of these intakes in terms of human drink-equivalents is roughly 0.25 g/kg per drink, or a range of 6--15 drinks/day during the last 6 months of self-administration prior to the brain being harvested. These levels of drinking are considered heavy in terms of human ethanol consumption (guidelines posted at [www.niaaa.nih.gov](www.niaaa.nih.gov)).

###### 

**Ethanol Consumption for monkeys used in this study**.

  Subject   Daily intake (g/kg)   Total intake (g/kg)   Blood ethanol concentration (*n*)
  --------- --------------------- --------------------- -----------------------------------
  5404      3.33 ± 0.24           2289.8                188 ± 17 (33)
  5497      1.76 ± 0.10           1670.8                105 ± 11 (33)
  6101      1.85 ± 0.012          1524.2                100 ± 9 (28)
  6304      1.17 ± 0.13           897.8                 63 ± 13 (30)
  6305      1.49 ± 0.08           1184.5                62 ± 10 (30)
  6306      2.70 ± 0.17           2757.7                173 ± 10 (35)

*Daily intake values and blood ethanol concentrations represent mean ± SEM*.

Dorsolateral prefrontal cortex
------------------------------

In the DLPFC, we observed a significant Group × Subunit interaction for the GRIA subunits \[*F*(3,39) = 3.576, *P* = 0.025\], with a significant decrease in GRIA4 (*P* = 0.002; Figure [1](#F1){ref-type="fig"}A). For the AMPA splice variants, we observed a significant Main Effect of Group \[*F*(1,79) = 6.891, *P* = 0.011\] and significant Group × Subunit interaction \[*F*(7,79) = 3.101, *P* = 0.007\], where *post hoc* analyses revealed a decrease in the GRIA4 flip variant (*P* \< 0.001) in the alcohol group (Figure [1](#F1){ref-type="fig"}B). GRIA3, GRIA3 flip and flop, and GRIA4 flop mRNAs were positively correlated with average daily intake and average BEC for the 6 months prior to necropsy (*P* \< 0.05). GRIA2 flop mRNA was positively correlated with BEC but not average intake (Table [3](#T3){ref-type="table"}).

![**Effect of chronic self-administration by cynomolgus macaques on AMPA receptor subunit expression in DLPFC**. Ethanol induced a significant Group × Subunit interaction, with *post hoc* analysis revealing a significant decrease in GRIA4 mRNA levels **(A)**. In addition, ethanol induced a significant effect on AMPA splice variant expression and a significant GROUP × Variant interaction, with *post hoc* analysis revealing a significant decrease GRIA4 flip variant in the ethanol group **(B)**. Black bar -- control subjects, gray bar -- ethanol subjects. Flip and flop variants are designated as "i" and "o," respectively. Asterisks indicate a significant difference compared to control subjects (*P* \< 0.05).](fpsyt-02-00072-g001){#F1}

###### 

**Correlational analysis of gene expression with average daily intake and average blood ethanol concentrations for the 6 months prior to necropsy**.

               DLPFC            OFC                ACC                                          
  ------------ ---------------- ------------------ ---------------- ---------------- ---------- -----------
  GRIA1 FLIP   −0.00833         −0.00835           −0.189           −0.233           −0.484     −0.553
  GRIA1 FLOP      0.311            0.276           −0.0703          −0.148           −0.327     −0.344
  GRIA2 FLIP      0.195            0.259           −0.646           −0.679           −0.528     −0.523
  GRIA2 FLOP      0.773         **   0.820\***     **   0.869\***   **   0.893\***      0.547      0.571
  GRIA3 FLIP   **   0.831\***   **   0.943\*\***      0.345            0.344            0.391      0.454
  GRIA3 FLOP      0.428            0.476              0.768            0.785            0.345      0.390
  GRIA4 FLIP      0.467            0.445              0.0481           0.108            0.438      0.417
  GRIA4 FLOP   **   0.840\***   **   0.883\***        0.732            0.756            0.626      0.640
  GRIK1           0.562            0.536              0.186            0.158            0.239      0.169
  GRIK2           0.628            0.636              0.189            0.151            0.145      0.0649
  GRIK3        −0.185           −0.157             −0.120           −0.133           −0.537     −0.548
  GRIK4           0.172            0.150           −0.0974          −0.129              0.178      0.127
  GRIK5           0.370            0.373              0.412            0.386            0.478      0.417
  PICK1           0.794            0.751              0.693            0.684            0.355      0.300
  GRIP         −0.266           −0.295             −0.473           −0.505              0.129      0.0628

*Values expressed are Pearson correlation coefficients (*r*^2^) for the six male monkeys that consumed alcohol in the present study. \**P* \< 0.05; \*\**P* \< 0.01. Bold values highlight statistical significance of Pearson correlations*.

Kainate receptor subunit mRNAs were significantly decreased in the ethanol group \[*F*(1,49) = 5.330; *P* = 0.026\]; however, there was no significant Group × Subunit interaction \[*F*(4,49) = 0.785; *P* = 0.542\] (Figure [2](#F2){ref-type="fig"}A). There were no significant differences in PICK1 or GRIP1 between the alcohol and control groups in this region (Figure [2](#F2){ref-type="fig"}B) and no significant correlations between the kainate receptor subunits, PICK1 or GRIP mRNA levels and average daily intake and average BEC for the 6 months prior to necropsy (Table [3](#T3){ref-type="table"}).

![**Effect of chronic self-administration on kainate receptor subunits, PICK1 and GRIP1 mRNA expression in the DLPFC**. Ethanol induced a significant decrease in kainate receptor subunit mRNA in the region; however there was no significant Group × Subunit interaction **(A)**. No significant differences were observed between the groups for PICK1 and GRIP1 **(B)**. Black bar -- control subjects, gray bar -- ethanol subjects.](fpsyt-02-00072-g002){#F2}

Orbitofrontal cortex
--------------------

In the OFC, there was no significant difference in GRIA receptor subunit mRNAs between the Groups \[*F*(1,39) = 0.000257, *P* = 0.987\] and no significant Group × Subunit interaction \[*F*(3,39) = 0.261, *P* = 0.853\] (Figure [3](#F3){ref-type="fig"}A). GRIA variant expression was significantly different between the groups \[*F*(1,70) = 19.504; *P* \< 0.001\], but there was no significant interaction observed \[*F*(7,79) = 0.319; *P* = 0.943\] (Figure [3](#F3){ref-type="fig"}B). GRIA 2 flop mRNA levels were significantly correlated with both average daily intake and average BEC for the 6 months prior to necropsy (Table [3](#T3){ref-type="table"}).

![**Effect of chronic self-administration by cynomolgus macaques on AMPA receptor subunit expression in OFC**. Ethanol self-administration did not affect AMPA receptor subunit mRNA expression in this region **(A)**, but did alter AMPA subunit splice variant expression **(B)**. Black bar -- control subjects, gray bar -- ethanol subjects.](fpsyt-02-00072-g003){#F3}

No significant difference was observed in kainate receptor subunit mRNA expression between the Groups \[*F*(1,49) = 0.637, *P* = 0.430\] and there was no significant Group × Subunit interaction \[*F*(4,49) = 1.840; *P* = 0.140\] (Figure [4](#F4){ref-type="fig"}A). Moreover, there were no significant differences in PICK1 or GRIP1 between the alcohol and control groups in this region (Figure [4](#F4){ref-type="fig"}B) and no significant correlations between the kainate receptor subunits, PICK1 or GRIP mRNA levels and average daily intake and average BEC for the 6 months prior to necropsy (Table [3](#T3){ref-type="table"}).

![**Effect of chronic self-administration on kainate receptor subunits (A), PICK1 and GRIP1 (B) mRNA expression in the OFC**. No significant differences were observed between the groups for any of the transcripts evaluated. Black bar -- control subjects, gray bar -- ethanol subjects.](fpsyt-02-00072-g004){#F4}

Anterior cingulate cortex
-------------------------

In contrast to the other prefrontal regions, there were no significant Main Effects or interactions for GRIA subunits (\[*F*(1,39) = 0.0289, *P* = 0.866\]; \[*F*(3,39) = 0.541, *P* = 0.657\] or GRIA splice variants (\[*F*(1,79) = 0.836, *P* = 0.364\] \[*F*(7,79) = 0.659, *P* = 0.706\]; Figures [5](#F5){ref-type="fig"}A,B, respectively). No significant difference was observed in kainate receptor subunit mRNA expression either between Groups \[*F*(1,49) = 0.185, *P* = 0.669\] or in Group × Subunit interaction \[*F*(4,49) = 0.260; *P* = 0.902\] (Figure [6](#F6){ref-type="fig"}A). In addition, there were no significant differences in PICK1 or GRIP1 between the alcohol and control groups (Figure [6](#F6){ref-type="fig"}B). No significant correlations were observed between AMPA subunits, AMPA splice variant, kainate subunits, PICK1 or GRIP mRNA levels and average daily intake and average BEC for the 6 months prior to necropsy (Table [3](#T3){ref-type="table"}).

![**Effect of chronic self-administration by cynomolgus macaques on AMPA subunit expression in ACC**. Ethanol did not alter the expression of AMPA receptor subunits **(A)** or AMPA splice variants **(B)** in this region. Black bar -- control subjects, gray bar -- ethanol subjects.](fpsyt-02-00072-g005){#F5}

![**Effect of chronic self-administration on kainate receptor subunits (A), PICK1 and GRIP1 (B) mRNA expression in the ACC**. No significant differences were observed between the groups for any of the transcripts evaluated. Black bar -- control subjects, gray bar -- ethanol subjects.](fpsyt-02-00072-g006){#F6}

Discussion
==========

The current findings indicate that chronic ethanol self-administration decreased the expression of mRNAs that encode specific AMPA and kainate receptor subunits. Significant decreases were observed in AMPA subunit splice variant expression and kainate subunit expression in DLPFC. Moreover, GRIA3 flip and flop variants as well as the GRIA4 flop variant expression was positively correlated with BECs as well as ethanol intake 6 months prior necropsy. Total AMPA splice variant expression was decreased in the OFC with GRIA2 flop mRNA expression levels positively correlated with BECs as well as ethanol intake 6 months prior necropsy. No changes in kainate receptor subunit expression or AMPA-related synaptic proteins, PICK1 and GRIP1, were observed in any of the three brain regions analyzed. These data support and expand the results of studies in humans (Gass and Olive, [@B20]; Ridge et al., [@B64]; Schumann et al., [@B67]; Ridge and Dodd, [@B63]) and non-human primates (Hemby et al., [@B26]; Acosta et al., [@B1]). The present results along with previous studies implicating GABAergic dysregulation suggests a glutamate/GABA imbalance in DLPFC and OFC that would likely disrupt information processing in prefrontal microcircuits and corresponding cortical fields known to be involved in cognitive functions altered by alcohol abuse and addiction (Figure [7](#F7){ref-type="fig"}). Future studies will be required to determine if alterations in iGluR and GABA-A subunit mRNA are reflected in receptor composition and how such alterations might affect the physiology of the neurons on which they are located.

![**Schematic map summarizing GABA-A and iGluR subunit changes in DLPFC, ACC and OFC**. Coronal section illustrating the general locations of tissue dissected for the DLPFC (green), ACC (blue) and OFC (red) used in this study. Changes in mRNA expression of GABAA, NR1 and AMPA subunits as well as synaptic proteins are indicated beside the respective regions.](fpsyt-02-00072-g007){#F7}

AMPA receptors contribute to fast neurotransmission while also mediating Ca^2+^ flux. The functional diversity of AMPA receptors subunits can be alternatively spliced to yield *flip* and *flop* variants with *flip* variants confer slower desensitization times to the receptor in which they are present, resulting in longer channel open times and increased neuronal excitability (Mosbacher et al., [@B48]; Koike et al., [@B37]). Studies have found these splice variants to be expressed in different ratios depending on development, drug administration, and disease state (Monyer et al., [@B47]; Eastwood et al., [@B17]). Kainate receptors exert smaller excitatory post-synaptic potentials than AMPA receptors, yet appear to contribute a significant prolonged depolarization under repetitive neuronal firing (Pinheiro and Mulle, [@B58]). Pre-synaptically localized kainate receptors modulate both excitatory and inhibitory neurotransmitter release. The mechanisms of kainate receptor regulation during alcoholism and other forms of synaptic plasticity is far less understood than AMPA or NMDA regulation. Previous studies have indicated that the intoxicating and reinforcing effects of ethanol are mediated in part by the effects on AMPA and kainate receptors (Valenzuela and Cardoso, [@B76]; Backstrom and Hyytia, [@B4]; Sanchis-Segura et al., [@B66]; Jones et al., [@B34]; Stuber et al., [@B70]). For example, acute ethanol decreases AMPA and kainate receptor-mediated currents in a variety of limbic brain regions (Weiner et al., [@B81]; Crowder et al., [@B15]; Carta et al., [@B13]; Moykkynen et al., [@B49]; Stuber et al., [@B70]). By contrast, chronic intermittent ethanol administration has been shown to increase AMPA and kainate receptor-mediated transmission in the basolateral amygdala (Lack et al., [@B40], [@B39]) and increase GluR3 flip variant mRNA expression in the hippocampus of rats (Bruckner et al., [@B11]). Currently, there are no published data correlating the effects of chronic ethanol consumption on AMPA or kainate receptor subunit expression or receptor binding in primate prefrontal cortex.

Rodent studies reveal that extracellular glutamate levels are elevated in the nucleus accumbens in mice with a history of high alcohol consumption (Szumlinski et al., [@B71]) as well as in rats in the basolateral amygdala during cue-induced reinstatement of alcohol intravenous self-administration (Gass et al., [@B21]). Moreover, bouts of moderate ethanol consumption increase *basal* glutamate levels in the CA3 region of the hippocampus (Chefer et al., [@B14]). An integral role of iGluR transmission is further implicated by several demonstrations that modulators at these receptors affect alcohol intake and reinstatement. Ethanol self-administration is reduced by competitive and non-competitive NDMA receptor antagonists (Rassnick et al., [@B62]; Bienkowski et al., [@B8]; Holter et al., [@B28]; Malpass et al., [@B43]) and competitive AMPA/kainate receptor antagonists (Stephens and Brown, [@B69]). Cue-induced reinstatement of ethanol maintained responding is reduced by lamotrigine, a glutamate release inhibitor (Vengeliene et al., [@B78]), competitive NMDA receptor antagonists (Backstrom and Hyytia, [@B4]; Bachteler et al., [@B3]), the NMDA receptor modulator acamprosate (Bachteler et al., [@B3]) as well as competitive AMPA/kainate antagonists (Backstrom and Hyytia, [@B4]; Sanchis-Segura et al., [@B66]), including topiramate (Knapp et al., [@B36]; Lynch et al., [@B42]).

Previous studies in humans demonstrate clearly the potential role of iGluR modulators in the regulation of alcohol intake, craving, withdrawal symptoms and other outcome measures (Krupitsky et al., [@B38]; Johnson, [@B32]). For example, topiramate reduces the percentage of heavy drinking days and improve self-reported outcomes in alcohol dependent individuals (Johnson et al., [@B33]). While topiramate exhibits multiple mechanisms of action, including sodium channel opening, AMAP/kainate and GABA-A receptor modulation, the effect on alcohol intake likely involves antagonism of kainate receptors, specifically, GluR5. Merging the effects of chronic alcohol intake on AMPA and kainate mRNA expression with documented or potential efficacy of pharmacological compounds is tenuous at best. Nevertheless, the present data do not provide insight on the involvement of prefrontal cortical regions in the observed preclinical or clinical efficacy of topiramate or lamotrigine. The possibility exists that blockade of glutamate release or GluR5 antagonism in other regions might mediate the effects of these compounds.

The current findings of altered AMPA dysregulation in the DLPFC offer a potential neurobiological substrate of the DLPFC associated cognitive dysfunction in alcoholics (Bechara, [@B6]; Pears et al., [@B56]). Furthermore, the results offer a biological basis into the potential use of compounds that selectively target AMPA receptors. For example, LY404187 or the enantiomer LY451646, allosteric AMPA receptor modulators (AMPAkines), preferentially affect GluR2 and GluR4 and potentiate the *flip* variants more so than the *flop* variants of these receptors. LY404187 selectively increased the probability of PFC pyramidal neuron firing in response to stimulation from hippocampal afferents (Baumbarger et al., [@B5]) and enhance cognitive performance in rodent models (Staubli et al., [@B68]) and memory encoding in humans (Ingvar et al., [@B30]). In the present scenario, reductions in GluR4 *flip* expression in the DLPFC could be overcome by amplifying glutamate transmission using compounds such as LY404187/LY451646. The possibility of a connection between decreased GluR4 *flip* expression and altered cognitive function as a function of chronic alcohol intake remains to be determined. Given the evidence of improved cognitive performance by allosteric AMPA modulators, it is reasonable to suggest that members of this family of compounds may prove beneficial in the treatment of cognitive dysfunction in alcoholics.

Previous studies in humans suggest the prefrontal cortex, especially fields located on the orbital and medial surfaces, play an important role in addiction and are rendered dysfunctional as a consequence of long-term alcohol consumption. Human alcoholics exhibit alterations in DLPFC cerebral blood flow and impairments in executive function during early abstinence (Zinn et al., [@B83]). Furthermore, alcohol craving has been associated also with increased functional activity of the DLPFC (George et al., [@B22]; Wrase et al., [@B82]; Tapert et al., [@B72]; Olbrich et al., [@B51]) and OFC (Wrase et al., [@B82]; Tapert et al., [@B73]; Myrick et al., [@B50]). OFC has been implicated in impulsivity (Jentsch and Taylor, [@B31]), response inhibition (Elliott et al., [@B18],[@B19]; Goldstein et al., [@B24]; Liddle et al., [@B41]), and the attribution as well as evaluation of stimulus salience (Thorpe et al., [@B74]; Tremblay and Schultz, [@B75]; Hikosaka and Watanabe, [@B27]; Goldstein and Volkow, [@B23]), all of which are impaired in alcohol and other addictions. Characterization of the biochemical basis of the functional and anatomical alterations in primate prefrontal cortex and associated behavioral deficits induced by chronic ethanol consumption are needed to better understand the neuropathological consequences of alcoholism as well as to develop and/or improve existing pharmacotherapies to reduce or alleviate such deficits.

There is no question that mRNA levels may not correlate precisely with protein abundance, an important next step is to include functional assessments of AMPA and kainate receptors in these cortical fields. Currently available antibodies enable the detection of AMPA subunits but can not differentiate *flip* and *flop* splice variants. In the current study, assessment of protein levels via Western blot analysis was not possible due to the small amount of dissected tissue and previous studies utilizing aliquots of the same tissue to examine GABA-A and iGluR subunits and synaptic proteins.

Accumulating evidence suggests that changes in DLPFC and OFCiGluR and GABA-A receptors may underlie the functional deficits resulting from chronic alcohol abuse (Bechara and Damasio, [@B7]; Goldstein and Volkow, [@B23]; Bechara, [@B6]). Examination of the effects of ethanol on cognitive function in the monkey as well as levels of receptor subunit expression, the class of neurons that are primarily affected, and the expression of related trafficking and anchoring proteins and their genes within these prefrontal regions will be fundamental to ascertaining the molecular pathology of prefrontal dysregulation in alcoholism.
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